India, Nov. 3 -- While reporting financial results for the third quarter on Tuesday, drug major Pfizer, Inc. (PFE) raised its adjusted earnings and revenue guidance for the full-year 2026, reflecting strong year-to-date performance and confidence in business.
For fiscal 2026, the company continues to project adjusted earnings in the range of $2.95 to $3.05 per share on revenues between $62.0 billion and $64.0 billion.
Previously, the company expected adjusted earnings in the range of $2.80 to $3.00 per share on revenues between $60.5 billion and $62.5 billion.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
In Tuesday's pre-market trading, PFE is trading on the NYSE at $30.54, down $0.17 or 0.55 perc...